文献速递肝胆胰外科围术期管理与 ERAS

脾动脉结扎调节门脉血流预防肝切除术后肝衰竭:一项随机对照试验

Portal flow modulation by splenic artery ligation to prevent posthepatectomy liver failure: A randomized controlled trial.
PubMed 文献 · Surgery · 2025-04-09

本研究为单中心随机对照试验,纳入92例开放肝切除患者,其中36例门静脉压>15 mmHg者随机分为脾动脉结扎组与对照组。脾动脉结扎显著降低术后肝衰竭B/C级发生率(16.67% vs 66.67%,P=.006)及综合并发症指数(8.70 vs 20.90,P=.034),为独立保护因素(调整相对风险0.29)。

要点

  • 门静脉压>15 mmHg者肝衰竭B/C级发生率显著升高(41.67% vs 3.57%,P<.001)。
  • 脾动脉结扎显著降低门静脉压及门静脉压-中心静脉压梯度。
  • 脾动脉结扎降低肝衰竭B/C级发生率及综合并发症指数,为独立保护因素。

核心结论

  • 脾动脉结扎可有效降低门静脉压>15 mmHg患者肝切除术后肝衰竭B/C级发生率,并降低综合并发症指数,为独立保护因素(调整相对风险0.29)。

主要发现

  • 92例中36例门静脉压>15 mmHg,其肝衰竭B/C级发生率41.67% vs 3.57%(P<.001),腹水量5,340 mL vs 1,055 mL(P<.001),综合并发症指数20.90 vs 8.70(P<.001)。
  • 随机亚组中脾动脉结扎组肝衰竭B/C级发生率16.67% vs 66.67%(P=.006),综合并发症指数8.70 vs 20.90(P=.034)。
  • 脾动脉结扎显著降低门静脉压及门静脉压-中心静脉压梯度,优于结扎前及对照组。

关键数值与推荐

  • 肝衰竭分级采用国际肝脏外科研究组(ISGLS)标准,主要终点为B级和C级肝衰竭。
  • 脾动脉结扎降低肝衰竭的调整相对风险为0.29。

临床怎么用

  • 对肝切除术后门静脉压>15 mmHg的患者,可考虑行脾动脉结扎以降低术后肝衰竭风险。

局限性

  • 研究因干预组主要终点出现统计学显著差异而提前终止,未达到计算样本量。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Posthepatectomy liver failure is a serious clinical issue with high mortality, similar in pathophysiology to small-for-size syndrome seen in liver transplantation. This study evaluates the efficacy of splenic artery ligation in reducing posthepatectomy liver failure in patients with portal venous pressure >15 mm Hg after hepatectomy. METHODS: This single-center, randomized controlled trial was conducted from May 2019 to November 2023. Eligible participants were patients scheduled for open hepatectomy for any indication. Patients with a portal venous pressure >15 mm Hg were randomized into splenic artery ligation and control groups in a 1:1 ratio. The primary outcomes were posthepatectomy liver failure grades B and C (International Study group of Liver Surgery criteria), and secondary outcomes included 90-day mortality, comprehensive complication index, and ascites volume. RESULTS: The study was terminated early, before reaching the calculated sample size, because the primary outcome in the intervention group demonstrated statistically significant results. Of the 92 patients, 36 had elevated portal venous pressure, which was associated with greater rates of posthepatectomy liver failure grades B and C (41.67% vs 3.57%, P < .001), increased ascites volume (5,340 mL vs 1,055 mL, P < .001), and a greater comprehensive complication index (20.90 vs 8.70, P < .001). In the randomized subset, splenic artery ligation significantly reduced portal venous pressure and the portal venous pressure-central venous pressure gradient compared with both presplenic artery ligation values and the control group and significantly lowered the incidence of posthepatectomy liver failure grades B and C (16.67% vs 66.67%, P = .006), comprehensive complication index (8.70 vs 20.90, P = .034). Splenic artery ligation was identified as an independent factor in reducing posthepatectomy liver failure (adjusted relative risk, 0.29). CONCLUSION: Splenic artery ligation is effective in reducing posthepatectomy liver failure in patients with high portal venous pressure after hepatectomy.

来源:Surgery,查看原文。版权归原作者所有。

引用

  1. Junrungsee S, Vipudhamorn W, Lapisatepun W, et al. Portal flow modulation by splenic artery ligation to prevent posthepatectomy liver failure: A randomized controlled trial. Surgery. 2025. PMID: 40204604. doi:10.1016/j.surg.2025.109351

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。